Harvard Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026

Published: 2026-05-12 16:51:49 ET HBIO

Published on 05/12/2026 at 04:51 pm EDT

Harvard Bioscience, Inc. reported earnings results for the first quarter ended March 31, 2026. For the first quarter, the company reported sales was USD 20.76 million compared to USD 21.77 million a year ago. Net loss was USD 3.42 million compared to USD 50.34 million a year ago.

Basic loss per share from continuing operations was USD 0.77 compared to USD 11.42 a year ago. Diluted loss per share from continuing operations was USD 0.77 compared to USD 11.42 a year ago.